With the first two phases not throwing up any adverse effects, the phase three trial of Bharat Biotech’s COVID-19 vaccine, Covaxin, is likely to start next month. Phase two of the trial that would go...

An expert panel at the Central Drugs Standard Control Organisation (CDSCO) on Friday recommended granting permission to Dr Reddy's Laboratories for conducting phase 2 clinical trials of the Russian...

US pharmaceutical giant Johnson & Johnson announced that it has temporarily paused its Covid-19 vaccine trial after a participant became unwell.

Mexico’s government announced on Saturday that it paid the World Health Organization $159.88 million to secure access to COVID-19 vaccines through the agency’s COVAX plan as countries across the globe...

The US could have enough coronavirus vaccine doses for every American by March 2021, Health and Human Services Secretary Alex Azar said.

China, which has four coronavirus vaccine candidates in stage 3 clinical trials, said on Friday that it is joining the COVID-19 vaccine alliance known as COVAX.

Union Health Minister Harsh Vardhan said on Sunday that the Centre is working on plans to procure 400-500 million doses of Covid-19 vaccine, which will be administered to up to 25 crore people by July...

There is growing hope that a vaccine against coronavirus may be given the green light by health regulators by the end of this year to be rolled out for a vaccination programme in six months’ time or...

Russia said on Wednesday it had agreed to supply the vaccine doses to Egypt via Pharco, which it described as one of the country’s leading pharmaceutical groups.

Telangana Governor Dr Tamilisai Soundararajan on Tuesday said that the whole world was looking towards Hyderabad for an effective COVID-19 vaccine.